Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Diclofenac
(Diclofenac sodium)		[2] Diclofenac; Diclofenac sodium[5] Diclofenac potassium ,
Diclofenac sodium (Diclofenac sodium, DICLOFENAC SODIUM, DICLOFENAC SODIUM 1.5%, DICLOFENAC SODIUM DELAYED RELEASE, DICLOFENAC SODIUM GEL, DICLOFENAC SODIUM TOPICAL SOLUTION),
Diclofenac ,
Diclofenac diethylamine ,
Diclofenac epolamine 💬 		[2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[4] 13, 34, 46, 271 💬